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INTRODUCTION
Interleukin (IL)-6 is an autocrine growth factor for mesan-
gial cells (1). IL-6 stimulates the proliferation of mesangial
cells and also enhances fibronectin expression by human me-
sangial cells (2). It was reported that in situ IL-6 mRNA
expression was associated with mesangial cell proliferation in
the patients with diabetic nephropathy (3). However, the me-
sangial cell proliferation is not a typical finding of diabetic
nephropathy, but acellular area can be shown in the patients
with nodular diabetic glomerulosclerosis. It has been report-
ed that high glucose decreased the cellularity of mesangial
cells (4, 5). It is not, however, reported whether high glucose
influences IL-6 production in mesangial cells. The results that
observed in the peripheral blood mononuclear cells were con-
troversial (6, 7).
There is evidence that the intrarenal renin-angiotensin sys-
tem is activated in diabetic nephropathy (8). Angiotensin II
(AGII) is involved in the progression of renal diseases includ-
ing diabetic nephropathy (9). AGII induces the synthesis of
matrix proteins and several cytokines and growth factors in-
cluding IL-6 in mesangial cells (10-13). The effects of AGII
blocking agents on IL-6 expression in mesangial cells are not
yet clearly elucidated (13).
Therefore, this study was designed to evaluate the direct
effects of high glucose in concert with AGII on IL-6 mRNA
expression or IL-6 secretion in mesangial cells and the mod-
ulation by blocking AGII with losartan, an AGII receptor
blocker, or captopril, an ACE inhibitor.
MATERIALS AND METHODS
Human mesangial cell culture
Portions of normal renal cortex were obtained from human
kidneys immediately after surgical nephrectomy. Collagenase
(Gibco BRL, Gaithersburg, MD, U.S.A.) treated glomeruli
were plated on culture dishes in DMEM medium (Gibco BRL)
containing 17% heat-inactivated fetal bovine serum (Sigma
Chemical Co., St. Louis, MO, U.S.A.) (14). Cells displayed
the typical spindle or stellate morphology. Immunofluores-
cent staining of the cells with antibodies to common leuko-
cyte antigen and factor VIII was negative, and the cells were
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Effects of High Glucose on Interleukin-6 Production in Human
Mesangial Cells
Interleukin (IL)-6 is an autocrine growth factor for mesangial cells. It is not known
whether high glucose influences IL-6 production in mesangial cells. Angiotensin
II (AGII) is involved in the progression of renal diseases including diabetic nephro-
pathy. Therefore, we evaluated the effects of high glucose in concert with AGII
on IL-6 production in human mesangial cells and the modulation by blocking AGII.
After 48 hr of culture, IL-6 mRNA expression was analyzed by reverse transcrip-
tion and polymerase chain reaction (PCR). Quantitative determination of IL-6
concentrations in the culture supernatants of mesangial cells was performed
using a sandwich enzyme immunoassay kit. Incubation of mesangial cells with
high glucose (450 mg/dL) reduced the ratio of PCR products for IL-6 to  -actin
on densitometric results, while AGII (10
-7 M) increased it. The IL-6 secretion in
the supernatant was also increased by AGII and decreased by high glucose. The
IL-6 mRNA expression and IL-6 secretion in combination of high glucose and AGII
were higher than those in high glucose and similar with those in control media.
The addition of losartan (10
-6 M) or captopril (10
-6 M) to high glucose had no addi-
tional effects on IL-6 production. These results suggest that whereas AGII increas-
es IL-6 production, high glucose decreases it. The IL-6 production of mesangial
cells in diabetic milieu may be complicated and depend on the local effects of
high glucose and/or AGII.
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Accepted : 7 January 2002capable of growth in D-valine substituted medium. Near
confluent mesangial cells in the third to fifth passage were
transferred to a 24-well plate, and were rested in serum-free
medium for 72 hr. Then mesangial cells were cultured in the
media containing 0.5% heat-inactivated fetal bovine serum
with D-glucose (Sigma, Louis, U.S.A.), AGII (Sigma, Louis,
U.S.A.), captopril (Sigma, Louis, U.S.A.), or losartan (Merck,
Whitehouse Station, U.S.A.). The concentrations of AGII
(10-7 M), captopril (10-6 M), or losartan (10-6 M) were used as
previously described (15, 16). Each group had three to four
separate experiments.
Reverse transcription (RT)-polymerase chain reaction
(PCR)
Mesangial cells were resuspended in RNAzol (Cinna/Bio-
tecx, Houston, TX, U.S.A.) and RT was performed using RT
kit (Boehringer, Mannheim, Melbourne, Australia), as pre-
viously described (17). The reaction mixture was incubated
for 60 min at 42℃and heated for 7 min at 90℃in thermo-
cycler (Crocodile III, Oncor Inc., Gaithersburg, MD, U.S.A.).
In order to quantitate the PCR products comparatively and
confirm the integrity of the products, we coamplified  -actin
in a companion tube. The primers based on the known se-
quences of human cDNAs were as follows.  -actin: sense was
5′ CCC CAG GCA CCA GGG CGT GAT 3′ and antisense
5′ GGT CAT CTT CTC GCG GTT GGC CTT GGG GT
3′ . IL-6: sense was 5′ GCG CCT TCG GTC CAG TTG 3′
and antisense 5′ CTC CTT TCT CAG GGC TGA G 3′ . RT
products were amplified with sense and anti- sense primers
in a reaction mixture: 10 mM Tris HCl (pH 8.3), 200  M
dNTP, 1.25 U Taq DNA polymerase, 1.5 mM MgCl2, 40
pmol for IL-6 and 20 pmol for  -actin primer. The mixture
was heated for 3 min at 94℃, and the PCR cycle consisted
of 1 min denaturation at 94℃, 1 min annealing at 60℃ for
-actin and 55℃for IL-6, 3 min extension at 72℃and final
extension for 7 min at 72℃. After amplification, PCR prod-
ucts were electrophoresed through a 1% agarose gel with
0.5  g/mL ethidium bromide to visualize the DNA bands.
The gel was photographed with Polaroid Type 665 positive/
negative film (Polaroid Corporation, Cambridge, Massachu-
setts, U.S.A.) (18). The bands on the negative film were scan-
ned by densitometry (Computer assisted dual wave length
flying spot scanner, CS-9000, Shimadzu Co., Kyoto, Japan).
The ratio of PCR products for IL-6 to  -actin according to
densitometric results also showed maximal sensitivity at 2  L
of cDNA and 38 cycles of PCR that we used in this study.
Sandwich enzyme immunoassay
Quantitative determination of IL-6 concentrations in the
culture supernatants of mesangial cells was performed using
a sandwich enzyme immunoassay kit (Quantikine; R&D Inc.,
Minneapolis, MN, U.S.A.). Standards and samples were pipet-
ted into the wells. After washing away unbound substances,
an enzyme-linked polyclonal antibody was added to the wells.
Following a wash, a substrate solution was added to the wells
and the intensity of the color was measured.
Statistics
Results are expressed as the mean±SD.Comparisons among
groups were made by analysis of variance, and comparisons
between groups were made using the Student’ s unpaired t-
test or the Mann-Whitney test. Significance was assigned at
the p<0.05 levels.
RESULTS
Effects of high glucose or AGII on IL-6 mRNA expression
PCR products, 211 bp in length corresponding to IL-6
mRNA and 263 bp to  -actin mRNA, were detected from
mesangial cells. We evaluated the effects of high glucose and
AGII on IL-6 expression in mesangial cells. After 48 hr of
culture, IL-6 mRNA expression was measured by RT-PCR.
Incubation with AGII (10-7 M) enhanced IL-6 expression by
30%, but in contrast, high glucose (450 mg/dL) reduced
IL-6 expression by 33% (Media 0.86±0.14, AGII 1.12±
0.05, high glucose 0.58±0.15; p<0.05) (Fig. 1, 2). The IL-
6 mRNA expression (0.95±0.25) in combination of high
glucose and AGII was similar to those in media (0.86±0.14)
and higher than those in high glucose (0.58±0.15).
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Fig. 1. Representative agarose gel analyzes of RT-PCR assays
performed to detect IL-6 message in human mesangial cells
incubated with media alone, angiotensin II (AGII) (10
-7 M), high
glucose (HG; 450 mg/dL), or high glucose with angiotensin II,
captopril (C; 10
-6 M) or losartan (L; 10-6 M).
IL-6
-actin
Marker Media AGII HG HG+AGII HG+C HG+LEffects of high glucose or AGII on IL-6 secretion
Similar to the results of IL-6 mRNA expression, the IL-6
secretion in the supernatant was increased by AGII and de-
creased by high glucose (Media 18.0±3.2, AGII 28.0±4.0,
high glucose 9.9±1.0 pg/mL) (Fig. 3). The IL-6 secretion
(20.0±4.0 pg/mL) in combination of high glucose and AGII
was also similar to those in media (18.0±3.2 pg/mL) and
higher than those in high glucose (9.9±1.0 pg/mL).
Effects of losartan or captopril
Furthermore, we tested the effects of losartan (10-6 M) or
captopril (10-6 M) administration on IL-6 production by me-
sangial cells in the presence of high glucose and fetal bovine
serum. The administration of these drugs at these concentra-
tions to high glucose had no additional effects on the IL-6
mRNA expression (high glucose 0.58±0.15, high glucose+
captopril 0.63±0.25, high glucose+losartan 0.68±0.20;
p>0.05) and secretion (high glucose 9.9±1.0 pg/mL, high
glucose+captopril 10.7±2.0 pg/mL, high glucose+losartan
12.2±5.0 pg/mL; p>0.05) (Fig. 1-3).
DISCUSSION
Various factors such as IL-1, tumor necrosis factor  , lipo-
polysaccharide, or immune complex stimulate IL-6 produc-
tion (2, 12, 19), but the effect of high glucose on IL-6 expres-
sion in human mesangial cells has not been reported yet. In
peripheral mononuclear cells there are controversies about the
effect of high glucose on IL-6 production. The results of one
study demonstrated that IL-6 production was suppressed by
elevated glucose concentration dose- and time-dependently
(6). Elevated glucose levels significantly alter the cytokine
production and concomitantly inhibit cellular proliferation.
In contrast, other study showed that hyperglycemia or ad-
vanced glycosylation end products stimulated IL-6 synthesis
and secretion (7). IL-6 levels of culture supernatants incu-
bated with 22 mM or 33 mM glucose showed considerable
increase over basal levels incubated with 11 mM glucose,
whereas those levels incubated with high concentration of
mannitol showed no increase.
In our study, high glucose reduces IL-6 mRNA expression
and IL-6 secretion in human mesangial cells. It was reported
that high glucose increases the production of transforming
growth factor (TGF)  and decreases the cellularity of mesan-
gial cells (4, 5). High glucose-induced decrease of IL-6 may
also be related to the decrease of cellularity in mesangial cells
when incubated in high glucose. The results in other cells
indicated that TGF  1 production is preceding the reduced
IL-6 production in condition of high glucose concentration
(6). Therefore, the decrease of IL-6 production in concert with
increase of TGF  1 may be involved in the early development
of diabetic glomerular hypertrophy. This may be different
from the data in the late stage of diabetic nephropathy that
in situ IL-6 mRNA expression was associated with mesangial
cell proliferation in the patients with diabetic nephropathy
(3). It is, however, unclear how high glucose reduced IL-6
expression. Further studies are necessary to investigate the
underlying mechanisms including intracellular transduction
pathway.
There is evidence that the intrarenal renin-angiotensin sys-
tem is activated in diabetic nephropathy (8) and that signals
for renin, angiotensinogen and ACE mRNA are stronger in
mesangial cells of patients with diabetes mellitus (20). It has
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Fig. 2. Effects of angiotensin II (AGII), high glucose (HG), or high
glucose with angiotensin II, captopril (C) or losartan (L) on IL-6
mRNA expression in human mesangial cells. *p<0.05 vs. media
alone; 
� p<0.05 vs. HG.
*
�
*
I
L
-
6
 
c
o
n
c
e
n
t
r
a
t
i
o
n
s
 
(
p
g
/
m
L
)
30
20
10
0
Media AGII HG HG+AGII HG+C HG+L
Fig. 3. Effects of angiotensin II (AGII), high glucose (HG), or high
glucose with angiotensin II, captopril (C) or losartan (L) on IL-6
secretion in human mesangial cells. *p<0.05 vs. media alone; 
� p<
0.05 vs. HG.
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*been reported that AGII receptors are present in abundance
in mesangial cells (21). Our study showed that AGII induced
the increase in IL-6 mRNA expression or IL-6 secretion. Other
study showed that AGII enhances DNA synthesis of mouse
mesangial cells through the mediation of IL-6 (10). AGII
has been also observed to induce cell hypertrophy (11).
It has been reported that hyperglycemia enhances the ex-
pression of AGII receptors and the local effects of AGII (22).
These suggest that hyperglycemia can act in synergy with
locally increased AGII levels in inducing diabetic glomeru-
lar hypertrophy (23). Therefore, the combined administra-
tion of high glucose and AGII may be useful to understand
the mechanisms in the development of diabetic nephropa-
thy. Our study showed that the IL-6 mRNA expression or
IL-6 secretion in combination of high glucose and AGII were
higher than those in high glucose alone and similar to those
in media. These indicate that the local effect of AGII may
be antagonistic to that of high glucose on IL-6 expression in
diabetes. In situ hybridization study showed that IL-6 mRNA
is expressed by glomerular resident cells and interstitial cells
in the renal tissue of patients with diabetic nephropathy and
that its expression may be associated with mesangial prolif-
eration (3). The IL-6 production of mesangial cells in diabet-
ic milieu may thus be complicated and depend on the local
effects of high glucose and/or AGII. We can speculate that
localized IL-6 production in mesangial cells may be decreased
at the stage of early diabetes and increased, at least partly by
AGII, at the late stage of diabetic nephropathy. At the late
stage the combined effects of AGII and IL-6 may aggravate
mesangial injury.
Our study showed that the administration of losartan or
captopril to mesangial cells cultured with high glucose and
fetal bovine serum had no additional effects on IL-6 mRNA
expression and IL-6 secretion. These indicate that AGII may
be not directly involved in the high glucose-induced alter-
ations in IL-6 production. In other study administration of
valsartan in therapeutic dosages in normal glucose concen-
trations did not influence stimulated production of IL-6 by
whole blood (13). It’ s unclear whether these findings may
reflect in vivo state and whether other concentrations of these
drugs may have some effects. 
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